KLOTHO-MRNA

European patent · EP4669333 · In force

Register entry

Publication number
EP4669333
Application number
EP24725642
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 22, 2024
Published
Dec 31, 2025
Granted
Jun 17, 2026
Protection ends at the latest
Mar 21, 2044
Next annual fee due
Mar 31, 2027
IPC classes
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
A61K 38/17 (2006.01)
A61Q 19/08 (2006.01)
A61P 43/00 (2006.01)
C12N 9/14 (2006.01)
C12N 9/24 (2006.01)
Priority
EP 23163488 22.03.2023
PCT application
PCT/US2024/021148 22.03.2024
PCT publication
WO2024/197254 26.09.2024
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 19, 2026

    Agent entered

    Representative
    PRINS Intellectual Property AG, Mellingerstrasse 12, 5443 Niederrohrdorf

    Published in Swissreg on 19.06.2026

  2. Jun 17, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 17.06.2026

Parties

Holder

ADvantage Therapeutics, Inc.

195 NW 40th Street, Miami, FL 33127, US

Agent

PRINS Intellectual Property AG

Mellingerstrasse 12, 5443 Niederrohrdorf

Inventor

HOFFMANN, Thomas

1220 Wien, AT

FERNANDEZ SANTANA III, Agustin

Coral Gables, FL 33134, US

SCHMIDT, Walter

1020 Wien, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.